Evaluation of Urolithin A Efficacy in Heart Failure Patients with Reduced Ejection Fraction: A Randomized, Double-blind, Crossover, Placebo-controlled Clinical Trial

CONCLUSION: The results of the present study do not support any positive effect of UA supplementation in improving echocardiographic and biochemical indices of HFrEF. Further studies with higher doses of UA and longer supplementation duration are encouraged to be conducted.CLINICAL TRIAL REGISTRATION NUMBER: IRCT20210216050375N1.PMID:38415449 | DOI:10.2174/0115748871279354240209101604
Source: Reviews on Recent Clinical Trials - Category: Cancer & Oncology Authors: Source Type: research